100% of moneycontrol users recommend buying Ind-Swift.
What's your call on Ind-Swift today?
Read 1 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Vaibhav Global Recommended on Jun 11th 2014
Recommended price 675.00 | Peak from reco 975.00 44.44%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ind-Swift is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 48.43 crore.The company has reported a standalone sales of Rs 178.16 crore and a Net Loss of Rs -20.93 crore for the quarter ended Jun 2014.
The company management includes S R Mehta - Chairman, N R Munjal - Vice Chairman, Gopal Munjal - Managing Director & CEO, V R Mehta - Joint Managing Director, Himanshu Jain - Director, Rishav Mehta - Director, K M S Nambiar - Director, R S Bedi - Director, H P S Chawla - Director, S K Mathur - Director, S P Sharma - Independent Director, Atul Saxena - Nominee Director, V K Arora - Non Promoter & Non Executive Director, J Thunuguntala - Additional Director.
It is listed on the BSE with a BSE Code of 524652 and the NSE with an NSE Code of INDSWFTLTD.
Its Registered office is at 781, Industrial Area - II , Chandigarh,Chandigarh - 160002.
Their Registrars are Alankit Assignment Ltd.